Indo Us Biotech Limited vs Nestle India Limited
A side-by-side comparison of Indo Us Biotech Limited (INDOUS) and Nestle India Limited (NESTLEIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Nestle India Limited leads INDOUS vs NESTLEIND on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability13
- Growth20
- Size & financial health04
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
NESTLEIND takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
INDOUS takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
NESTLEIND takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 21.3% CAGR over last 5 years", "Company has delivered good sales growth of 23.1% CAGR over last 5 years"]
- − []
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 94.0%", "Company has been maintaining a healthy dividend payout of 77.2%"]
- − ["Stock is trading at 47.32 times its book value"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.